Trump administration pick for Health and Human Services department could cause rise in preventable disease, health expert ...

Former FDA Commissioner Scott Gottlieb, who served in the first Trump administration, is raising concerns with Republicans ...

Scott Gottlieb said he’s worried that Trump’s pick to run HHS, Robert F. Kennedy Jr., will follow through on past antivaccine ...

Scott Gottlieb, who served as commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first ...

GEN highlights six AI-based drug discoverers worthy of note based on pipeline or platform progress, and in one instance, a ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an ...

Despite Pfizer's (NYSE: PFE) recent struggles with falling earnings and a bid by an activist investor to unseat its ...

For me at the moment, the stock I'm wishing I held in my portfolio is Palantir Technologies (NASDAQ: PLTR). Why do I wish I ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

The company has growing revenues, a strong balance sheet, a high FCF margin, and no major maturities. Click here to read an ...

Are there any Black Friday sales for income investors? Here are three ultra-high-yield dividend stocks that are bargain buys. As a business development company (BDC), it must return at least 90% of ...